DCP Logo
  • Home
  • About
    • DCP program
    • DCP program history
    • Structural Genomic Consortium
    • Probe contributions
  • Show Probes
    • All
    • Kinase
    • GPCR
    • Ion channel
    • Epigenetics
    • Other enzymes
    • Other targets
  • Order set
  • Download
  • Information
    • FAQ
    • Probe resources
    • Donate probes
    • Contact
    • Funding
    • Update history
All probes Probe criteria Further information Usage Order Properties Structure Compound analysis Potency Selectivity Data download
  • Probe criteria
  • Further information
  • Usage
  • Order
  • Properties
  • Structure
  • Compound analysis
  • Potency
  • Selectivity
  • Data download

Usage recommendations for probe BAY-876 and control BAY-588


In cells

Good metabolic stability; almost complete inhibition of the proliferation of TE‐8 and TE‐11 cells with 0.1 nM; tested in ovarian cancer cell lines (SKOV-3, OVCAR-3, HEY) with 75 nM.

Use the recommended concentration to avoid off-target toxicity and/or off-target activity. Using concentrations that are higher than recommended could lead to false positive or confounding results.

In vivo

High oral bioavailability; rat PK in vivo: Clb = 0.33 L/h/kg, VSS = 0.79 L/kg, t1/2 = 4.9 h, F = 85 %; tested in female NSG mice for 28 days with p.o. dose of 1.5, 3, or 4.5 mg/kg/day.